141 – 150 of 207
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: Evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
- Contribution to journal › Article
-
Mark
Tumor karyotype predicts clinical outcome in colorectal cancer patients
- Contribution to journal › Article
-
Mark
Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients.
- Contribution to journal › Article
-
Mark
High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparation.
- Contribution to journal › Article
-
Mark
Identification of a commonly amplified 4.3 Mb region with overexpression of the C8FW gene, encoding a phosphoprotein regulated by mitogenic pathways, but not of the MYC gene in MYC-containing double minutes in myeloid malignancies.
- Contribution to journal › Article
- 2003
-
Mark
Genetic profiling of colorectal cancer liver metastases by combined comparative genomic hybridization and G-banding analysis
- Contribution to journal › Article
-
Mark
Trisomy 8 as the sole chromosomal aberration in myelocytic malignancies. a multicolor and locus-specific fluorescence in situ hybridization study.
- Contribution to journal › Article
-
Mark
A Novel Gene, MSI2, Encoding a Putative RNA-binding Protein Is Recurrently Rearranged at Disease Progression of Chronic Myeloid Leukemia and Forms a Fusion Gene with HOXA9 as a Result of the Cryptic t(7;17)(p15;q23).
- Contribution to journal › Article
-
Mark
MYC is not overexpressed in a case of chronic myelomonocytic leukemia with MYC-containing double minutes
- Contribution to journal › Letter
-
Mark
Clinical and genetic studies of ETV6/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate.
- Contribution to journal › Article
